Circulating miRNAs Are Generic and Versatile Therapeutic Monitoring Biomarkers in Muscular Dystrophies

Scientific Reports - United Kingdom
doi 10.1038/srep28097
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Arrhythmias in the Muscular Dystrophies

Heart Rhythm
Cardiovascular MedicinePhysiologyCardiology
2012English

Advances in Gene Therapy for Muscular Dystrophies

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2016English

Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine

Frontiers in Immunology
AllergyImmunology
2020English

Limb Girdle Muscular Dystrophies in India

Neurology India
Neurology
2008English

New Questions About the Muscular Dystrophies.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1995English

miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives

Targeted Oncology
Cancer ResearchOncologyPharmacology
2017English

Circulating miRNAs as Diagnostic Biomarkers for Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2020English

Timed Immersion Expiration Measures in Patients With Muscular Dystrophies

Archives of Physiotherapy
2020English

Endothelial and Circulating C19MC microRNAs Are Biomarkers of Infantile Hemangioma

JCI insight
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy